Ads
related to: acute myeloid leukemia diagram- AML Treatment Option
See If an AML Treatment Option
May Be Able To Help Your Patients.
- Testing For AML
Learn About The Importance of
Testing For Mutations in AML.
- Clinical Recommendations
Info On a Treatment Recommendation
From An AML Treatment Guideline.
- View Dosing Guidelines
Clinical Dosing Guidelines For
an AML Treatment Option.
- Learn About The MOA
Watch a Video That Explains
The Mechanism of Action.
- View The Clinical Data
Explore The Clinical Data
For an AML Treatment Option.
- AML Treatment Option
Prescription-treatment-website.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Diagram showing the cells in which AML starts. Date: 30 July 2014 (released by CRUK) Source: Original email from CRUK: Author: Cancer Research UK: Permission (Reusing this file) This image has been released as part of an open knowledge project by Cancer Research UK. If re-used, attribute to Cancer Research UK / Wikimedia Commons
Myeloid tissue, in the bone marrow sense of the word myeloid (myelo-+ -oid), is tissue of bone marrow, of bone marrow cell lineage, or resembling bone marrow, and myelogenous tissue (myelo-+ -genous) is any tissue of, or arising from, bone marrow; in these senses the terms are usually used synonymously, as for example with chronic myeloid ...
Myeloid leukemia is a type of leukemia affecting myeloid tissue. Types include: Acute myeloid leukemia: A cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. Chronic myelogenous leukemia: A cancer of the white ...
The underlying pathophysiology of acute myeloid leukemia consist of maturational arrest of the bone marrow cell during the early stages of development. A myeloblast is an immature precursor cell that will change into a monocyte, healthy white blood cell. In AML, Myeloblast do not mature but grow and multiply with regulation.
Transient myeloid leukemia is a pre-leukemic condition. [30] [31] [32] Clonal hematopoiesis is a common age-related phenomenon with a low risk of progression to myelodysplastic syndrome (MDS) and leukemia. [33] Once MDS has developed, the risk of progression to acute leukemia can be assessed using the International Prognostic Scoring System .
Ad
related to: acute myeloid leukemia diagram